Skip to main content

Table 1 Demographic and clinical characteristics of prior negative biopsy cohort

From: A urine-based Exosomal gene expression test stratifies risk of high-grade prostate Cancer in men with prior negative prostate biopsy undergoing repeat biopsy

Total Cohort, N

229

Median Age (IQR)

65 (60–70)

Median PSA ng/mL (IQR)

6.1 (4.71–7.5)

Family History, N (%)

172 (75.1%)

Ethnicity, N (%)

 African Americans

33 (14.4%)

 Asian/Pacific Islander

4 (1.7%)

 Caucasian

164 (71.6%)

 Hispanic

17 (7.4%)

 Other

11 (4.8%)

DRE non-suspicious, N (%)

152 (66.4%)

Grade Groups, N (%)

 Benign

157 (68.6%)

 GG1

44 (19.2%)

 GG2

17 (7.4%)

 GG3

6 (2.6%)

 GG4

4 (1.4%)

 GG5

1 (0.4%)